Warner Carr
Publications by Year
Research Areas
Asthma and respiratory diseases, Respiratory and Cough-Related Research, Inhalation and Respiratory Drug Delivery, Allergic Rhinitis and Sensitization, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases(2019)123 cited
- → ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”(2018)73 cited
- → ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice(2020)69 cited
- → Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks(2023)61 cited
- → Severe asthma exacerbations in the United States:(2021)38 cited
- → Biologic use and outcomes among adults with severe asthma treated by US subspecialists(2022)25 cited
- → Real-world severe asthma biologic administration and adherence differs by biologic(2023)22 cited
- → Update on the safety of long-acting β-agonists in combination with inhaled corticosteroids for the treatment of asthma(2009)15 cited
- → Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma(2020)13 cited
- → Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma(2023)12 cited